Our analysis of large transcriptomic dataset identified higher expression levels of CD47 mRNA, but not of CRT mRNA, in primary lung adenocarcinomas with EGFR mutations as compared to those with different oncogenic mutations. This evidence concerns the gene CD47 and lung adenocarcinoma.